C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2007
08/22/2007	EP1124568B1 Polyspecific binding molecules and uses thereof
08/22/2007	EP0933423B1 Meltrins
08/22/2007	CN1333082C Method for high efficiency extracting collagen by alkali swelling acid enzymolysis
08/22/2007	CN1332979C New type antibiotic peptide of peptaibol and preparing technique
08/22/2007	CN1332977C Novel techykinin peptides, precursor peptides thereof and genes encoding the same
08/22/2007	CN1332712C Oncolytic virus therapy
08/22/2007	CN101023181A Method for enhancing production of isoprenoid compounds
08/22/2007	CN101023180A O-linked glycoforms of polypeptides and method to manufacture them
08/22/2007	CN101023172A Method of producing glycoprotein composition
08/22/2007	CN101023098A Method of detecting hepatitis B virus s antigen
08/22/2007	CN101022828A Inhibition of factor b, the alternative complement pathway and methods related thereto
08/22/2007	CN101020916A Process of preparing active peptide antagonizing pathogenic bacteria of fruits and vegetable
08/22/2007	CN101020712A Rice GAMYB conjugate-1 and polynucleotide coding this polypeptide
08/22/2007	CN101020709A Process of extracting collagen from chromium-containing waste leather
08/22/2007	CN101019890A Donkey-hide gelatin degrading product
08/22/2007	CN101019889A Prepn process of brain protein hydrolysate injection
08/21/2007	US7259295 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants
08/21/2007	US7259293 Expression of eukaryotic peptides in plant plastids
08/21/2007	US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule.
08/21/2007	US7259245 For diagnosis of cell proliferation/differentiation disorders of hedgehog (Hh) cascade signaling sequences
08/21/2007	US7259242 Protein molecular weight ladder made of a fusion protein that comprises thioredoxin, a modified thioredoxin, or a truncated thioredoxin.
08/21/2007	US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity.
08/21/2007	US7259141 prepared via chemoenzymatic techniques; contain a 1,2,3-triazole moeity attached to the sugar group; glycosylating a vancomycin aglycone with a sugar transferase, then reacting with an alkyne via a 1,3-dipolar cycloaddition; treating vancomycin resistant infections
08/21/2007	US7259022 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
08/21/2007	US7259014 Fusion protein delivery system and uses thereof
08/21/2007	US7259007 Filamentous fungal host cells to produce glycans without mannosylphosphate residues, therapy
08/21/2007	US7259003 Genetically engineered microorganism for fermentaion of phenylalanine and threonine
08/21/2007	US7259000 Polynucleotides encoding chimeric chemokine receptors
08/21/2007	US7258999 parathyroid hormone (PTH) for drug screening, diagnosis and development of therapies for bone related disorders; genetic engineering
08/21/2007	US7258998 Cell culture medium
08/21/2007	US7258997 Folded recombinant tumor necrosis polypeptide comprising substituted proline for use as tool in treatment of inflammatory disorders
08/21/2007	US7258996 Contacting lactic acid bacteria with milk to form a mixture, wherein bacteria comprises Lactobacillus helveticus, fermenting mixture under conditions to partially hydrolyze the casein of milk into casein-derived peptides to provide a fermented dairy product containing metalloproteinases inhibitory agent
08/21/2007	US7258991 Antibody to bladder cancer nuclear matrix protein and its use
08/21/2007	US7258989 Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and use
08/21/2007	US7258986 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
08/21/2007	US7258985 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
08/21/2007	US7258866 M. canis-containing ringworm vaccine
08/21/2007	US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed
08/21/2007	CA2247966C Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof
08/21/2007	CA2178517C Neisseria meningitidis capsular polysaccharide conjugates
08/21/2007	CA2154325C Heparan sulfate 6-o-sulfotransferase
08/21/2007	CA2139468C Methods for preventing degradation of protein c
08/21/2007	CA2131703C Compositions and methods for the identification and synthesis of sialyltransferases
08/21/2007	CA2099069C Recombinant feline herpesvirus vaccine
08/21/2007	CA2071950C Collagen binding protein as well as its preparation
08/21/2007	CA2070004C Cloned glutamic acid decarboxylase
08/16/2007	WO2007090675A2 Novel oxidoreductases and uses thereof
08/16/2007	WO2007090294A1 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment
08/16/2007	WO2007090290A1 Synthesis of sialic acid in plants
08/16/2007	WO2007067627A3 Isolating prions from blood via lipoproteins
08/16/2007	WO2007029003A3 Method of preparing a hydrogel
08/16/2007	WO2006119337A8 Fluorescent proteins and uses thereof
08/16/2007	WO2005106010A3 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
08/16/2007	WO2005047860A3 Antibodies to alpha-synuclein
08/16/2007	WO2004113548A3 Distillers solubles as a constituent for nisin and lactic acid production from dairy cheese by products
08/16/2007	WO2004100774A3 Receptors and membrane-associated proteins
08/16/2007	WO2004000997A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007	WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007	US20070192886 TAT-044 and methods of assessing and treating cancer
08/16/2007	US20070192885 TAT-039 and methods of assessing and treating cancer
08/16/2007	US20070192880 Horming response element binding transregulators
08/16/2007	US20070191592 amidated peptide; stress-related conditions
08/16/2007	US20070191298 Beta Secretase Genes
08/16/2007	US20070191280 High Purity Lipopeptides
08/16/2007	US20070191270 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2007	US20070190644 With vaccinia virus complement control protein, poxvirus encoded
08/16/2007	US20070190616 Using transglutaminase to form polymers from fusion peptides; enhances antigenicity; use in vaccines
08/16/2007	US20070190615 Use of a gene coding for the C4BP protein beta chain for producing recombinant dimeric proteins
08/16/2007	US20070190614 Methods and compositions for vitamin K epoxide reductase
08/16/2007	US20070190612 31 Human Secreted Proteins
08/16/2007	US20070190611 Long-acting polypeptides and methods of producing same
08/16/2007	US20070190610 comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO (erythropoietin) peptide ; improving a biological half life of an hGH polypeptide
08/16/2007	US20070190609 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents; atopic allergy, and related disorders
08/16/2007	US20070190608 Thermostable alpha-amylases
08/16/2007	US20070190607 Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function
08/16/2007	US20070190606 Methods for Production of Proteins
08/16/2007	US20070190605 Gene products of bacillus licheniformis which form odorous substances and improved biotechnological production methods based thereon
08/16/2007	US20070190604 Novel Gene Products From Bacillus Licheniformis Forming Or Decomposing Polyamino Acids And Improved Biotechnological Production Methods Based Thereon
08/16/2007	US20070190603 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
08/16/2007	US20070190602 Mutant protein having the peptide-synthesizing activity
08/16/2007	US20070190601 Modified integrase and methods of use
08/16/2007	US20070190600 Mechanosensitive ion channels and methods of use
08/16/2007	US20070190599 Anti-glypican 3 antibody
08/16/2007	US20070190598 Method of reducing leachate from protein a affinity media
08/16/2007	US20070190597 Oligosaccharide modification and labeling of proteins
08/16/2007	US20070190587 Reporter polypeptide for use as bioluminescent marker
08/16/2007	US20070190581 Density enhanced protein tyrosine phosphatases
08/16/2007	US20070190578 Method of site specific labeling of proteins and uses therefor
08/16/2007	US20070190577 Biologically active synthetic thyrotropin and cloned gene for producing same
08/16/2007	US20070190575 Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
08/16/2007	US20070190565 That are useful, e.g., as reagents or targets in assays applicable to treatment and diagnosis of protein kinase-associated or other 2150-associated disorders
08/16/2007	US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents
08/16/2007	US20070190558 Cationic Steroid Antimicrobial Compositions and Methods of Use
08/16/2007	US20070190554 Novel binding site for retigabine on KCNQ5
08/16/2007	US20070190553 Novel rat voltage-gated potassium channel
08/16/2007	US20070190538 Chimeric polymerases
08/16/2007	US20070190524 Non-M, non-O HIV-1 strains, fragments and uses
08/16/2007	US20070190074 Modified hpv e6 and e7 genes and proteins useful for vaccination
08/16/2007	US20070190072 In vivo efficacy of ny-eso-1 plus adjuvant
08/16/2007	US20070190065 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein

1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 1125